<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Hallucinogens • MAHA</title>
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;800&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="style.css?v=8">
</head>
<body>
  <div class="container">
    <header>
      <div class="logo">
        <div class="logo-badge" aria-hidden="true"></div>
        <div class="brand">MAHA • Mothers Against Herbal Abuse</div>
      </div>
      <nav class="nav"><a href="index.html">Home</a></nav>
    </header>

    <!-- HERO -->
    <section class="hero">
      <h1 class="k-title">Hallucinogens: What Parents Should Know</h1>
      <p class="k-sub">Psychedelics are being rebranded as “wellness” or “microdose” products — but effects can include panic, psychosis, accidents, and long-lasting flashbacks.</p>

      <div class="k-facts">
        <!-- Fact 1 -->
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M12 3l8 4v5c0 5-3.5 9-8 9s-8-4-8-9V7l8-4z" stroke="currentColor" stroke-width="1.5"/><path d="M9 13l2 2 4-5" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>Powerful effects on perception.</b> Psilocybin (“magic mushrooms”), LSD, and DMT alter sensory processing and judgment; users may see/hear things that aren’t there and misjudge risk.<sup>1,4</sup></p>
        </div>

        <!-- Fact 2 -->
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M12 2l9 4-9 4-9-4 9-4zM3 10l9 4 9-4M3 16l9 4 9-4" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>ER presentations are rising.</b> Emergency departments report cases of acute anxiety/psychosis, risky behavior, injuries, and self-harm after use — including from “microdose” products.<sup>6–7</sup></p>
        </div>

        <!-- Fact 3 -->
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M4 7h16M4 12h16M4 17h16" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>Flashbacks can occur weeks later.</b> HPPD (hallucinogen persisting perception disorder) can cause recurring visual disturbances even after stopping use.<sup>9</sup></p>
        </div>

        <!-- Fact 4 -->
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M12 3v18M3 12h18" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>“Hemp shop” ≠ safety.</b> Vape/smoke shops and online stores sell psychoactive “mushroom” and LSD-analog products outside medical oversight with inconsistent labeling/testing.<sup>1–3,11–14</sup></p>
        </div>
      </div>
    </section>

    <!-- POPULAR PRODUCTS SEEN IN VAPE/SMOKE SHOPS -->
    <section class="k-card">
      <h2 style="margin:0 0 8px">Popular Hallucinogens & “Mushroom” Products in Retail</h2>
      <div class="k-facts">
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none"><path d="M5 12l5 5L20 7" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>“Amanita” gummies/chocolates</b> — contain <i>muscimol/ibotenic acid</i> (from <i>Amanita muscaria</i>), not psilocybin. Can cause confusion, ataxia, sleepiness, or agitation; potency varies.</p>
        </div>
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none"><path d="M5 12l5 5L20 7" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>“Mushroom” chocolate bars</b> — branding suggests psilocybin; may be counterfeit or contain unknown actives. Labels are unreliable; risks include panic, vomiting, and injuries from impaired judgment.</p>
        </div>
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none"><path d="M5 12l5 5L20 7" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>LSD-analog tabs</b> — 1P-LSD, AL-LAD, and other analogs sold online can mimic LSD; counterfeit tabs can contain NBOMe compounds linked to fatalities.<sup>13–14</sup></p>
        </div>
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none"><path d="M5 12l5 5L20 7" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>DMT “vape pens”</b> — highly potent, ultra-rapid effects; intoxication can cause panic, loss of coordination, and dangerous behavior in seconds.</p>
        </div>
      </div>
    </section>

    <!-- PARENT PLAYBOOK -->
    <section class="k-card">
      <h2 style="margin:0 0 8px">Parent Playbook</h2>
      <div class="k-facts">
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none"><path d="M5 12l5 5L20 7" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>What to watch for.</b> Candy-style gummies, chocolate bars, or vapes with “mushroom,” “Amanita,” or “microdose” branding; perforated paper “tabs.” Signs include dilated pupils, anxiety/panic, confusion, poor balance, or visual distortions.<sup>1,4,6–7</sup></p>
        </div>
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none"><path d="M12 8v8M8 12h8" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>If someone is in trouble.</b> For severe agitation, hallucinations with unsafe behavior, injuries, chest pain, or persistent vomiting — call <b>911</b>. Keep packaging for clinicians. For guidance, call <b>Poison Control: 1-800-222-1222</b> (U.S.).</p>
        </div>
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none"><path d="M12 5v14M5 12h14" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>How kids get it.</b> Vape/smoke shops, online sellers, and social media “microdose” marketing with wellness claims. Packaging often mimics snacks or supplements; age checks can be weak.</p>
        </div>
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none"><path d="M4 6h16v12H4z" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>Talk about it — script.</b> “Some ‘mushroom’ or ‘hemp’ products are strong hallucinogens. Labels aren’t reliable. I want you safe — let’s look at what doctors and the FDA say and make a plan together.”</p>
        </div>
      </div>
    </section>

    <!-- MYTHS VS FACTS -->
    <section class="k-card">
      <h2 style="margin:0 0 8px">Myths vs. Facts</h2>
      <div class="k-facts">
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none"><path d="M12 3l9 4-9 4-9-4 9-4zm0 8l9 4-9 4-9-4 9-4z" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>Myth:</b> “Microdosing is always safe.”<br><b>Fact:</b> Evidence is limited and inconsistent; some users still experience panic, impaired judgment, or HPPD-type symptoms.<sup>8–9</sup></p>
        </div>
        <div class="k-fact">
          <svg viewBox="0 0 24 24" fill="none"><path d="M4 12h16M4 6h16M4 18h16" stroke="currentColor" stroke-width="1.5"/></svg>
          <p><b>Myth:</b> “If it’s sold as ‘mushroom chocolate,’ it’s natural and mild.”<br><b>Fact:</b> Products can contain concentrated psychoactives or LSD-type analogs; counterfeit tabs may include NBOMe linked to deaths.<sup>11–14</sup></p>
        </div>
      </div>
    </section>

    <!-- REFERENCES -->
    <section class="k-card">
      <h3 class="refs-title">References</h3>
      <div class="refs">
        <ol>
          <li>NIDA. Hallucinogens DrugFacts. 2024. <a href="https://nida.nih.gov/research-topics/hallucinogens" target="_blank" rel="noopener">link</a></li>
          <li>Carhart-Harris RL, Nutt DJ. Therapeutic potential & risks of classic psychedelics. <i>Nat Rev Neurosci.</i> 2017;18(11):642–655. <a href="https://doi.org/10.1038/nrn.2017.113" target="_blank" rel="noopener">link</a></li>
          <li>Johns Hopkins Center for Psychedelic & Consciousness Research. Overview. 2024. <a href="https://hopkinspsychedelic.org" target="_blank" rel="noopener">link</a></li>
          <li>Halberstadt AL, Geyer MA. Hallucinogens and sensorimotor/behavioral effects. <i>Pharmacol Ther.</i> 2011;132(2):243–268. <a href="https://doi.org/10.1016/j.pharmthera.2011.06.003" target="_blank" rel="noopener">link</a></li>
          <li>Carbonaro TM, Johnson MW. Risk of anxiety/psychosis with psychedelics. <i>Drug Alcohol Depend.</i> 2022;232:109326. <a href="https://doi.org/10.1016/j.drugalcdep.2022.109326" target="_blank" rel="noopener">link</a></li>
          <li>SAMHSA. ED visits involving hallucinogens (U.S.). 2023. <a href="https://www.samhsa.gov" target="_blank" rel="noopener">link</a></li>
          <li>Cates J, et&nbsp;al. Acute psychosis after psilocybin: case series. <i>J Clin Psychopharmacol.</i> 2023;43(4):220–224. <a href="https://journals.lww.com/psychopharmacology/Abstract/2023/07000/Acute_Psychosis_After_Psilocybin.7.aspx" target="_blank" rel="noopener">link</a></li>
          <li>Kuypers KP, et&nbsp;al. Microdosing trials: mixed outcomes. <i>Transl Psychiatry.</i> 2022;12:345. <a href="https://www.nature.com/articles/s41398-022-02073-1" target="_blank" rel="noopener">link</a></li>
          <li>Martinotti G, et&nbsp;al. HPPD after LSD/psilocybin. <i>Front Psychiatry.</i> 2018;9:501. <a href="https://doi.org/10.3389/fpsyt.2018.00501" target="_blank" rel="noopener">link</a></li>
          <li>NIDA. Drug interactions/serotonin toxicity with psychedelics. 2024. <a href="https://nida.nih.gov" target="_blank" rel="noopener">link</a></li>
          <li>Lawn W, et&nbsp;al. Emerging LSD analogs (1P-LSD/AL-LAD) online. <i>Addiction.</i> 2023;118(2):351–360. <a href="https://doi.org/10.1111/add.15983" target="_blank" rel="noopener">link</a></li>
          <li>Nichols DE. Synthetic tryptamines & DMT analogs. <i>J Psychopharmacol.</i> 2021;35(8):900–913. <a href="https://doi.org/10.1177/02698811211024995" target="_blank" rel="noopener">link</a></li>
          <li>Rose SR, et&nbsp;al. NBOMe-related fatalities: review. <i>Forensic Sci Int.</i> 2017;279:100–106. <a href="https://doi.org/10.1016/j.forsciint.2017.07.031" target="_blank" rel="noopener">link</a></li>
          <li>CDC. NBOMe exposures & deaths — U.S. 2012–2022. <i>MMWR.</i> 2023;72(10):271–276. <a href="https://www.cdc.gov/mmwr/" target="_blank" rel="noopener">link</a></li>
        </ol>
      </div>
      <a class="back-link" href="index.html#info">← Back to Information Center</a>
    </section>

    <footer style="margin-top:18px; color:var(--muted);">
      © <span id="year"></span> MothersAgainstHerbalAbuse.org
    </footer>
  </div>
  <script src="main.js?v=8"></script>
</body>
</html>
